SCHEMBL6659623

SCHEMBL6659623

Cc1ccc(S(=O)(=O)N(c2ccc(OC(=O)N3CCOCC3)cc2)[C@@](C)(C(=O)OC(C)(C)C)C(=O)C2CS(=O)(=O)CCN2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
RAB9A P51151 2/20 0.37
NPY2R P49146 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
KMT2A Q03164 4/20 0.35
MEN1 O00255 3/20 0.35
ALOX5 P09917 1/20 0.34
ALDH1A1 P00352 2/20 0.33
GAA P10253 1/20 0.33
USP2 O75604 1/20 0.33
PLA2G1B P04054 1/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
ATG4B Q9Y4P1 1/20 0.33
KEAP1 Q14145 1/20 0.33
NFE2L2 Q16236 1/20 0.33
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6660613 0.94 NPY2R (0.35) CYP1A2CYP2C9CYP2C19NPY2RKMT2A
SCHEMBL6659012 0.93 NPY2R (0.35) CYP1A2CYP2C9CYP2C19NPY2RKMT2A
SCHEMBL6663224 0.92 CYP1A2 (0.44) CYP1A2CYP2C9CYP2C19RAB9ANPY2R
SCHEMBL6664426 0.86 ALDH1A1 (0.33) KMT2AMEN1ALDH1A1NPSR1KDM4E
SCHEMBL6666784 0.80 POLB (0.32) ALDH1A1GAAKDM4E
SCHEMBL6634464 0.79 NPY2R (0.36) CYP1A2CYP2C9CYP2C19NPY2RKMT2A
SCHEMBL3869878 0.79 CYP1A2 (0.41) CYP1A2CYP2C9CYP2C19RAB9ANPY2R
SCHEMBL5850900 0.78 CYP1A2 (0.43) CYP1A2CYP2C9CYP2C19RAB9ANPY2R
SCHEMBL6632912 0.77 NPY2R (0.36) CYP1A2CYP2C9CYP2C19NPY2RKMT2A
SCHEMBL5655126 0.77 CYP2C9 (0.39) CYP1A2CYP2C9CYP2C19RAB9ANPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000051-B1 CARBAMYLOXY COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARM INC (US) 2004-05-19 EP claimed